Add to ORKGPolymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemi
Genetic polymorphisms are important factors in the effects and toxicity of chemotherapeutics. To ana...
Acute lymphoblastic leukemia (ALL) is a malignant disease of the white blood cells. The etiology of ...
The interindividual variation in the activity of xenobiotic metabolizing enzymes and DNA repair gene...
Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, a...
Multidrug resistance-related proteins (MRPs) 2, 3 and 5 are involved in the efflux of drugs used in ...
CONTEXT: Despite the advances in the cure rate for acute lymphoblastic leukemia, approximately 25% o...
Every year, acute lymphoblastic leukaemia (ALL) affects about 400 children aged <15 years in France,...
Acquired genetic characteristics of acute lymphoblastic leukemia (ALL) cells are used to individuali...
Infections are a major cause of morbidity and mortality in children with acute lymphoblastic leukemi...
Acute lymphoblastic leukemia (ALL) is a well-known malignant disorder affecting both children and ad...
The use of risk-directed chemotherapy for childhood acute lymphoblastic leu- kemia (ALL) has improve...
SummaryAcute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of ...
[[abstract]]BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) has been hypothesized to have a...
Background. Increased activity of multidrug resistance (MDR) genes has been associated with treatmen...
Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 a...
Genetic polymorphisms are important factors in the effects and toxicity of chemotherapeutics. To ana...
Acute lymphoblastic leukemia (ALL) is a malignant disease of the white blood cells. The etiology of ...
The interindividual variation in the activity of xenobiotic metabolizing enzymes and DNA repair gene...
Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, a...
Multidrug resistance-related proteins (MRPs) 2, 3 and 5 are involved in the efflux of drugs used in ...
CONTEXT: Despite the advances in the cure rate for acute lymphoblastic leukemia, approximately 25% o...
Every year, acute lymphoblastic leukaemia (ALL) affects about 400 children aged <15 years in France,...
Acquired genetic characteristics of acute lymphoblastic leukemia (ALL) cells are used to individuali...
Infections are a major cause of morbidity and mortality in children with acute lymphoblastic leukemi...
Acute lymphoblastic leukemia (ALL) is a well-known malignant disorder affecting both children and ad...
The use of risk-directed chemotherapy for childhood acute lymphoblastic leu- kemia (ALL) has improve...
SummaryAcute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of ...
[[abstract]]BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) has been hypothesized to have a...
Background. Increased activity of multidrug resistance (MDR) genes has been associated with treatmen...
Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 a...
Genetic polymorphisms are important factors in the effects and toxicity of chemotherapeutics. To ana...
Acute lymphoblastic leukemia (ALL) is a malignant disease of the white blood cells. The etiology of ...
The interindividual variation in the activity of xenobiotic metabolizing enzymes and DNA repair gene...